MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled “Radiopharmaceuticals Market Analysis, 2025–2030.”
This report provides a detailed assessment of the Radiopharmaceuticals Market, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.

Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.

Download a FREE PDF Sample of the Report: (Discover the market potential, platform-specific insights, and key industry trends.) https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Radiopharmaceuticals Market Timeline Overview

-Historical Years: 2020-23

-Base Years: 2024

-Forecast year - 2025-2030

This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.

Radiopharmaceuticals Market Outlook

According to the report, The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30. With the increasing burden of the geriatric population, the incidence of multiple diseases, including cancer, cardiovascular diseases (CVDs), etc.

The report also examines consumer preferences, regulatory impacts, and investment trends that will shape the market’s trajectory over the next decade.

Radiopharmaceuticals Market Drivers:

Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.

Radiopharmaceuticals Market Trends:

Increasing Quest for New Radioisotopes & Radiopharmaceuticals – Driven by several limitations associated with the production of certain alpha-emitting isotopes, currently utilized in radiopharmaceuticals, the biopharma companies have begun to explore alternative radioisotopes, such as 211At, 223Radium, etc. For instance, in 2024, Novartis AG started a phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors. The newer radioisotopes tend to have intriguing opportunities for both imaging and therapy while potentially overcoming existing limitations. Further, coupled with an increase in cancer cases globally, the critical need to reduce the risks associated with conventional radiation therapy, has led to the exploration of newer radiopharmaceuticals. This, in turn, is expected to further drive the Global Radiopharmaceuticals Market during the forecasting years.

View Full Report (All Data, In One Place): (Explore in-depth analyses, technological trends, and investment patterns.) https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

Radiopharmaceuticals Market Segmentation

The study categorizes the Radiopharmaceuticals Market into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.

By Radioisotope

• Technetium 99
• Fluorine 18
• Iodine 131
• Gallium 68
• Iodine 123
• Others (Yttrium 90, Indium 111, etc.)

By Indication

• Oncology
• Cardiology
• Gastroenterology
• Nephrology
• Others (Neuroendocrinology, Neurology, etc.)

By Type

• Diagnostic
• Therapeutic

By End User

• Hospitals
• Medical Imaging Centers
• Others (Specialty Clinics, Research Organizations, etc.)

Geographical Analysis

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

The report presents detailed insights into the Radiopharmaceuticals Market’s geographical expansion, highlighting key trends and opportunities across the following geographies:

Talk to Our Industry Analyst: Get personalized insights into company strategies and regional market dynamics.) https://www.marknteladvisors.com/query/talk-to-our-consultant/radiopharmaceuticals-market.html

Leading Companies in Radiopharmaceuticals Market Worldwide: Players, Analysis & Future Outlook

Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharm, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc., and Others, are the top players in the Radiopharmaceuticals Market.

Key Highlights of the Report

• Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
• Growth Drivers & Challenges: Clear insights into factors fueling or restraining market expansion.
• Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
• Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.

Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences

Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/radiopharmaceuticals-market.html

Frequently Asked Questions (FAQ)

1. What is the projected growth rate of the Radiopharmaceuticals Market?
   2. What are the major factors driving this market’s growth?
   3. Which regions are expected to lead the Radiopharmaceuticals Market?
   4. Who are the prominent players in the Radiopharmaceuticals Market?
   5. How is the competition structured in this market?
   6. How can I access the full report?

About us:

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.       

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.